LENSAR, Inc. (LNSR): Price and Financial Metrics
GET POWR RATINGS... FREE!
LNSR Stock Price Chart Interactive Chart >
LNSR Price/Volume Stats
| Current price | $8.10 | 52-week high | $12.71 |
| Prev. close | $8.25 | 52-week low | $3.16 |
| Day low | $8.01 | Volume | 22,700 |
| Day high | $8.20 | Avg. volume | 35,927 |
| 50-day MA | $8.14 | Dividend yield | N/A |
| 200-day MA | $7.86 | Market Cap | 88.75M |
LENSAR, Inc. (LNSR) Company Bio
LENSAR, Inc. develops laser technologies. The Company provides autoprecision laser and proprietary 3-D imaging, measurement, and guidance system for refractive cataract surgery. LENSAR serves the healthcare industries throughout the United States.
Latest LNSR News From Around the Web
Below are the latest news stories about LENSAR Inc that investors may wish to consider to help them evaluate LNSR as an investment opportunity.
LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceORLANDO, Fla., September 02, 2021--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the H.C. Wainwright 23rd Annual Global Investment Conference. |
LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual ConferenceORLANDO, Fla., August 16, 2021--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021. |
LENSAR Reports Second Quarter 2021 Financial Results and Provides Business UpdateORLANDO, Fla., August 05, 2021--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2021 and provided an update on key strategic and operational initiatives. |
LENSAR to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021ORLANDO, Fla., July 29, 2021--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s second quarter 2021 financial results will be released before market open on Thursday, August 5, 2021. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, August 5, 2021 to discuss the financial results and recent corp |
LENSAR Announces In-Person Demonstrations of Its Next Generation ALLY™ System and Multiple Data Presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2021 Annual MeetingORLANDO, Fla., July 15, 2021--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced a total of 12 abstracts highlighting LENSAR’s technology have been accepted for presentation at the 2021 Annual Meeting of the American Society of Cataract and Refractive Surgeons, being held July 23-27, 2021 in Las Vegas, NV. |
LNSR Price Returns
| 1-mo | 1.12% |
| 3-mo | -2.64% |
| 6-mo | -0.25% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 11.72% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...